eIF4E Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF4E monoclonal antibodies for investigating eIF4E's role in cellular processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF4E, or eukaryotic translation initiation factor 4E, is a critical component involved in the regulation of mRNA translation and is essential for the initiation of protein synthesis. eIF4E functions are pivotal in cellular growth, proliferation, and response to stress, making it a significant player in cancer biology and other diseases. Dysregulation of eIF4E has been implicated in various pathological conditions, highlighting its importance as a potential therapeutic target. Understanding eIF4E's role in translation regulation can provide valuable insights into disease mechanisms and potential treatment strategies. Research utilizing eIF4E monoclonal antibodies can advance knowledge in areas such as cancer research, developmental biology, and cellular stress responses. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to scientific understanding of translation regulation and disease mechanisms.